Ron van Eijsden Email

Ron van Eijsden Work

• Chief Business Officer @ ENPICOM (January 2026 - Present)
• Interim CBO and Commercial Director, Strategic Advisor in Life Sciences @ Strategic Business Development (October 2015 - Present)
• Chief Commercial Officer (CCO) @ Intravacc (February 2025 - November 2025)
• Chief Business Officer @ Batavia Biosciences (April 2022 - February 2025)
• Director Of Business Development @ Pepscope (July 2021 - March 2022)
• Operationally support HAL Allergy @ HAL Allergy Group (March 2021 - June 2021)
• Operationally support HALIX @ HALIX B.V. (March 2021 - June 2021)
• Managing Director and Head of European Operations @ Catalyst Clinical Research (April 2019 - September 2020)
• General Manager and Head of European Operations Medelis Europe (a WCCT Global company) @ WCCT Global (November 2016 - April 2019)
• Director of Business Development @ Accelovance (now Linical Accelovance Group) (April 2016 - October 2016)
• Business Development and Clinical Support (Self-employed) @ DCprime bv (August 2015 - April 2016)
• Business Development Director and Managing Director (Self-employed) @ Talentmark (August 2013 - July 2015)
• Sr. Director EU @ DOCS (January 2008 - July 2013)
• Business Director @ DOCS (January 2006 - December 2007)
• Country Manager @ Kelly Services (November 2003 - December 2005)
• Manager Production, Product Development and QC and QA @ Kreatech Diagnostics (February 1994 - September 1996)
• Post-Doctoral Scientist @ University of Amsterdam (September 1994 - February 1996)
• PhD student @ Leiden University (September 1989 - August 1994)
• Biology @ University of Amsterdam (January 1984 - January 1989)